Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis
Biomolecules · 2026
DOI: 10.3390/biom16101513 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Stephen W Harris und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Wright State University, 30 E. Apple St., Suite 3290, Dayton, OH 45409, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Tissue Inhibitor of Metalloproteinases, Matrix Metalloproteinases. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.
Abstract (Originalsprache)
Chronic liver disease represents a substantial global health burden, yet effective anti-fibrotic therapies remain elusive, largely due to an incomplete understanding of extracellular matrix (ECM) remodeling. While historical research prioritized the role of matrix metalloproteinase (MMP) deficiency in fibrogenesis, clinical outcomes indicate that broad-spectrum MMP modulation is paradoxically ineffective. This review synthesizes current evidence to demonstrate that hepatic fibrosis is driven by a complex regulatory imbalance wherein tissue inhibitors of metalloproteinases (TIMPs) sustain a pathological microenvironment. We highlight that TIMPs facilitate fibrogenesis through two primary mechanisms: the inhibition of MMP-mediated ECM degradation and the suppression of apoptosis in activated hepatic stellate cells (HSCs), a process exacerbated by mechanotransduction-driven feedback loops. Importantly, we address the functional redundancy within the TIMP family, as evidenced by the progression of fibrosis in TIMP-1-deficient models, which challenges traditional linear regulatory paradigms. Ultimately, we propose that the future of fibrosis treatment necessitates a shift from broad-spectrum enzyme modulation toward precision molecular strategies, including small-molecule inhibition, antisense oligonucleotides, and epigenetic reprogramming aimed at restoring the physiological MMP/TIMP equilibrium within the fibrotic niche.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Wright State University, 30 E. Apple St., Suite 3290, Dayton, OH 45409, USA.
- Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
- Gastroenterology Research Unit, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
- Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic and Foundation, 200 1st Street SW, Rochester, MN 55905, USA.
ORCID-Profile: Stephen W Harris, Robert C Huebert
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health
Zitieren
APA
Harris, S. W., Tyagi, P., & Huebert, R. C. (2026). Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis. Biomolecules. https://doi.org/10.3390/biom16101513
Vancouver
Harris SW, Tyagi P, Huebert RC. Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis. Biomolecules. 2026. doi:10.3390/biom16101513
BibTeX
@article{Harris2026,
author = {Harris, Stephen W and Tyagi, Purnima and Huebert, Robert C},
title = {Tipping the Balance: Context and Cell-Specific Regulation of MMPs and TIMPs in Liver Fibrosis},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16101513}
}
EUVIMED